Estats Units - anglès - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

Estats Units - anglès - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

Estats Units - anglès - NLM (National Library of Medicine)

virtus pharmaceuticals llc - calcium ascorbate (unii: 183e4w213w) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 60 mg

Estats Units - anglès - NLM (National Library of Medicine)

trigen laboratories, llc - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), calcium pantothenate (unii: 568et80c3d) (calcium cation - unii - ferrous cation 130 mg - folivane™-ob is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemia. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

Estats Units - anglès - NLM (National Library of Medicine)

trigen laboratories, inc. - ferrous sulfate (unii: 39r4tan1vt) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - ferrous cation 525 mg - for the treatment of iron deficiency and prevention of concomitant folic acid deficiency. for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid. contraindicated in patients with pernicious anemia and in the rare instance of hypersensitivity to folic acid. hemochromatosis and hemosiderosis are contraindications to iron therapy.

Estats Units - anglès - NLM (National Library of Medicine)

jaymac pharma - leucovorin (unii: q573i9dvlp) (leucovorin - unii:q573i9dvlp), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), levomefolate magnesium (unii: 1vzz62r081) (levomefolic acid - unii:8s95dh25xc), ferrous cysteine glycinate (unii: 8b4op7rk5n) (ferrous cation - unii:gw89581owr), 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium (unii: 6wjm73t46k) (1,2-docosahexanoyl-sn-glycero-3-phosphoserine - unii:dvy07ilf1w), 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium (unii: 9abd9drk7b) (1,2-icos - leucovorin 2.5 mg - clinical dietary management of major depressive disorder.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sigma company limited - iron polymaltose, quantity: 318 mg (equivalent: iron, qty 100 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 8 april 2002: for the treatment of iron deficiency anaemia in the following circumstances: * when oral therapy is contraindicated. * when enteric absorption of iron is defective. * when patient non-compliance or persistent gastrointestinal intolerance makes oral therapy impractical.

Estats Units - anglès - NLM (National Library of Medicine)

martin ekwealor pharmaceuticals, inc. - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - myferon 150 forte is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias. myferon 150 forte is contraindicated in patients with a known hypersensitivity to any of the components of this product. hemochromatosis and hemosiderosis are contraindications to iron therapy.

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - elemental iron + folic acid + zinc - capsule - 50 mg + 500 mcg + 22.5 mg

Filipines - anglès - FDA (Food And Drug Administration)

foramen products corporation; distributor: eadriex pharmaceuticals phils inc - ferrous. fumarate , riboflavin (vitamin b2) , cyanocobalamin (vitamin b12) , folic acid - capsule - 500 mg (eq. to 165 mg elemental iron) + 2 mg + 3 mcg + 230 mcg